Autoantibodies in COVID-19: implications for disease severity and clinical outcomes.
Saved in:
| Title: | Autoantibodies in COVID-19: implications for disease severity and clinical outcomes. |
|---|---|
| Authors: | Galipeau Y; Department of Biochemistry, Microbiology and Immunology, Faculty of Medicine, University of Ottawa, Ottawa, ON, Canada., Cooper C; The Ottawa Hospital Research Institute, Ottawa, ON, Canada., Langlois MA; Department of Biochemistry, Microbiology and Immunology, Faculty of Medicine, University of Ottawa, Ottawa, ON, Canada.; Centre for Infection, Immunity and Inflammation (CI3), University of Ottawa, Ottawa, ON, Canada. |
| Source: | Frontiers in immunology [Front Immunol] 2025 Jan 06; Vol. 15, pp. 1509289. Date of Electronic Publication: 2025 Jan 06 (Print Publication: 2024). |
| Publication Type: | Journal Article; Review; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1664-3224 |
|---|---|
| DOI: | 10.3389/fimmu.2024.1509289 |
